The association of serum C-reactive protein albumin ratio with polycystic ovarian syndrome

Beauty Begum; Salma Khatun; Mitra Biswas; Syma Akter

doi:10.18203/2320-1770.ijrcog20231906

Authors

Beauty Begum Department of Obstetrics and Gynecology, Nachole Upazilla Health Complex, Chapa Nawabganj, Bangladesh
Salma Khatun Department of Obstetrics and Gynecology, Colonel Maleque Medical College Hospital, Manikganj, Bangladesh
Mitra Biswas Department of Obstetrics and Gynecology, Proactive Medical College and Hospital, Narayanganj, Bangladesh
Syma Akter Araihazar Upazilla Health Complex, Narayanganj, Bangladesh

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20231906

Keywords:

PCOS, CRP, Albumin, Anovulation, Infertility

Abstract

Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder among women, characterized by various symptoms and long-term risks. Reliable diagnostic methods are needed to predict and diagnose PCOS. This study aimed to assess the serum C reactive protein/albumin ratio as a potential predictor and diagnostic tool for PCOS.

Methods: This cross-sectional analytical study was conducted at the department of obstetrics and gynecology, Sir Salimullah Medical College and Mitford Hospital, Dhaka, from September 2018 to August 2019. The study included 80 participants aged 18 to 45 years, with 40 healthy subjects in group I and 40 diagnosed cases of PCOS in group II. Serum C-reactive protein and serum albumin levels were measured, and data were analyzed using descriptive statistics and Unpaired t-tests.

Results: The study group had a mean age of 23.98±2.61, while the comparison group had a mean age of 23.85±2.79. Serum CRP levels were significantly higher in newly diagnosed PCOS cases (5.73±3.35) compared to non-PCOS cases (2.89±0.85) (p<0.001). The study group had a significantly higher mean CRP: albumin ratio (0.123±0.07) compared to the comparison group (0.067±0.02) (p<0.001).

Conclusions: This study found that serum CRP and the CRP/albumin ratio were increased in PCOS subjects, while serum albumin levels did not differ significantly from non-PCOS subjects. These findings suggest that the serum CRP/albumin ratio could be a potential marker for predicting and diagnosing PCOS.

Metrics

Metrics Loading ...

References

Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12(6):673-83.

Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28-38.

Gill H, Tiwari P, Dabadghao P. Prevalence of polycystic ovary syndrome in young women from North India: A Community-based study. Indian J Endocrinol Metab. 2012;16:S389.

Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol. 2011;24:223-7.

Fatima P, Ishrat S, Rahman D, Banu J, Deeba F, Begum N, et al. Quality and quantity of infertility care in Bangladesh. Mymensingh Med J. 2015;24:70-3.

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91(11):4237-45.

Rosenfield RL. The diagnosis of polycystic ovary syndrome in adolescents. Pediatrics. 2015;136:1154-65.

Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565-92.

Witchel SF, Oberfield S, Rosenfield RL, Codner E, Bonny A, Ibáñez L, et al. The Diagnosis of Polycystic Ovary Syndrome during Adolescence. Horm Res Paediatr. 2015;1.

Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011;95(3):1048-58.

Kalyan S, Patel MS, Kingwell E, Côté HCF, Liu D, Prior JC. Competing Factors Link to Bone Health in Polycystic Ovary Syndrome: Chronic Low-Grade Inflammation Takes a Toll. Sci Rep. 2017;7(1):3432.

Boulman N, Levy Y, Leiba R, Shachar S, Linn R, Zinder O, Blumenfeld Z. Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab. 2004;89(5):2160-5.

Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001;86(6):2453-5.

Spritzer PM, Lecke SB, Satler F, Morsch DM. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction. 2015;149(5):R219-27.

Kalyan S, Hitchcock CL, Sirrs S, Pudek M, Prior JC. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy. Pharmacotherapy. 2010;30(5):442-52.

Kalyan S, Goshtesabi A, Sarray S, Joannou A, Almawi WY. Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case-control study of women from Bahraini medical clinics. BMJ Open. 2018;8(10):e021860.